Centogene N.V. Stock

Stocks

39K

NL0014040206

Internet Services

OTC Markets Traded
End-of-day quote Hanseatische Wertpapierboerse Hamburg 2026-05-21 5-day change 1st Jan Change
0.1100 EUR -1.79% Intraday chart for Centogene N.V. -.--% +15.79%
3 months+7.84%
6 months+10.00%

Valuation: Centogene N.V.

Market Cap 2.61M 2.99M 2.41M 2.22M 4.18M 288M 4.28M 28.79M 11.32M 141M 11.22M 10.97M 485M P/E 2022
-2.24x
P/E 2023 -2.1x
Enterprise Value 63.85M 73.06M 58.92M 54.31M 102M 7.04B 105M 704M 277M 3.45B 274M 268M 11.86B EV / Sales 2022
2.03x
EV / Sales 2023 2.79x
Free-Float
95.16%
Yield 2022 *
-
Yield 2023 -
1 day-1.79%
3 months+7.84%
6 months+10.00%
Current year+15.79%
Current year 0.09
Extreme 0.0915
0.12
1 year 0.09
Extreme 0.0902
0.18
3 years 0.02
Extreme 0.021
0.3
5 years 0.02
Extreme 0.021
3.84
10 years 0.02
Extreme 0.021
3.84
Manager TitleAgeSince
Chief Executive Officer - 2025-02-03
Director of Finance/CFO - -
Chief Operating Officer 56 2015-12-31
Director TitleAgeSince
Chairman 59 2017-06-30
Director/Board Member 48 2018-12-31
Director/Board Member 70 2016-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-1.79%-.--%+5.77%-95.87% 3.75M
-4.63%+0.30%-11.06%+37.22% 529B
-7.26%-6.02%-42.98%+45.22% 287B
-2.13%-2.79%-20.01%+52.84% 147B
-12.30%+21.20%+655.14%+2,520.54% 107B
+0.43%-0.34%-31.25%+166.25% 98.32B
-4.75%-2.63%-22.70%+24.57% 93.2B
-1.23%-1.78%+4.77%-0.38% 86.64B
-1.19%-4.00%-23.01%+116.46% 80.23B
-4.27%-2.32%-24.77%+26.02% 38.4B
Average -3.91%-3.39%+48.99%+289.29% 146.73B
Weighted average by Cap. -4.72%-2.91%+28.36%+231.68%

Financials

2022 2023
Net sales 47.47M 54.32M 43.81M 40.38M 76.11M 5.23B 77.8M 524M 206M 2.56B 204M 200M 8.82B 48.54M 55.54M 44.79M 41.28M 77.81M 5.35B 79.54M 535M 211M 2.62B 209M 204M 9.02B
Net income -31.84M -36.44M -29.38M -27.08M -51.05M -3.51B -52.18M -351M -138M -1.72B -137M -134M -5.92B -35.53M -40.66M -32.79M -30.22M -56.96M -3.92B -58.23M -392M -154M -1.92B -153M -149M -6.6B
Net Debt 24.17M 27.66M 22.3M 20.56M 38.75M 2.66B 39.61M 267M 105M 1.3B 104M 102M 4.49B 61.24M 70.08M 56.51M 52.09M 98.18M 6.75B 100M 675M 266M 3.31B 263M 257M 11.38B
Logo Centogene N.V.
Crown LiquidationCo NV in liquidatie, is a commercial company. The company focuses on rare diseases, transforming clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. The company's platform includes epidemiological, phenotypic, and genetic data reflecting a global population, as well as a biobank of blood samples from these patients. The company's pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. The Company's Clinical Diagnostics segment provides targeted genetic sequencing and diagnostic services to patients through its distribution partners and customers, which are typically physicians, laboratories or hospitals.
Employees
384

Net sales - Rate of surprise